Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleImproved survival in patients with unresectable stage III EGFR‐mutant adenocarcinoma with upfront EGFR‐tyrosine kinase inhibitors.AuthorsWang, Sheng‐Yuan; Lai, Ching‐Han; Chen, Chian‐Wei; Yang, Szu‐Chun; Chang, Chao‐Chun; Lin, Chia‐Ying; Yen, Yi‐Ting; Tseng, Yau‐Lin; Su, Po‐Lan; Lin, Chien‐Chung; Su, Wu‐ChouPublicationThoracic Cancer, 2022, Vol 13, Issue 2, p182ISSN1759-7706Publication typeArticleDOI10.1111/1759-7714.14237